CVS Health Corp. R (CVS.DE) Financials
CVS.DE Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
June 30, 2024 | 235.2 billion | 165.2 billion |
March 31, 2024 | 231.4 billion | 162.7 billion |
Dec. 31, 2023 | 225.9 billion | 156.6 billion |
Sept. 30, 2023 | 237.4 billion | 167.0 billion |
CVS.DE Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
June 30, 2024 | 2.3 billion | 123.9 million |
March 31, 2024 | 3.9 billion | 126.9 million |
Dec. 31, 2023 | -3.2 billion | 114.9 million |
Sept. 30, 2023 | 2.1 billion | 145.5 million |
CVS.DE Net Income
Date | Net Income |
---|---|
June 30, 2024 | 1.6 billion |
March 31, 2024 | 1.0 billion |
Dec. 31, 2023 | 1.9 billion |
Sept. 30, 2023 | 2.1 billion |
CVS.DE Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
June 30, 2024 | 15.1 billion | 72.8 billion | 16.3 billion |
March 31, 2024 | 12.1 billion | 68.0 billion | 16.4 billion |
Dec. 31, 2023 | 10.4 billion | 67.5 billion | 16.1 billion |
Sept. 30, 2023 | 15.3 billion | 72.0 billion | 17.2 billion |
CVS.DE Shares Outstanding
CVS.DE Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
June 30, 2024 | 594.3 million | - | 9.6 billion | - |
March 31, 2024 | 653.2 million | - | 9.5 billion | - |
Dec. 31, 2023 | 824.1 million | - | 9.2 billion | 891.0 million |
Sept. 30, 2023 | 514.8 million | - | 9.2 billion | - |
CVS.DE Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
June 30, 2024 | 85.0 billion | 72.5 billion |
March 31, 2024 | 81.9 billion | 70.3 billion |
Dec. 31, 2023 | 84.9 billion | 72.3 billion |
Sept. 30, 2023 | 84.8 billion | 72.0 billion |
CVS.DE
Price: €52.58
Dividend Yield: 5.57%
Forward Dividend Yield: 5.06%
Payout Ratio: 52.57%
Dividend Per Share: 2.66 EUR
Earnings Per Share: 3.83 EUR
P/E Ratio: 12.97
Exchange: GER
Sector: Healthcare
Industry: Healthcare Plans
Market Capitalization: 62.5 billion
Average Dividend Frequency: 3
Years Paying Dividends: 7
DGR3: 7.49%
DGR5: 30.00%